A review of antimicrobial peptides and their therapeutic potential as anti-infective drugs
- PMID: 16020284
- PMCID: PMC1497874
- DOI: 10.1080/02713680590968637
A review of antimicrobial peptides and their therapeutic potential as anti-infective drugs
Abstract
Purpose: Antimicrobial peptides (AMPs) are an essential part of innate immunity that evolved in most living organisms over 2.6 billion years to combat microbial challenge. These small cationic peptides are multifunctional as effectors of innate immunity on skin and mucosal surfaces and have demonstrated direct antimicrobial activity against various bacteria, viruses, fungi, and parasites. This review summarizes their progress to date as commercial antimicrobial drugs for topical and systemic indications.
Methods: Literature review.
Results: Despite numerous clinical trials, no modified AMP has obtained Food & Drug Administration approval yet for any topical or systemic medical indications.
Conclusions: While AMPs are recognized as essential components of natural host innate immunity against microbial challenge, their usefulness as a new class of antimicrobial drugs still remains to be proven.
References
-
- Kaufmann H, Medzhitov R, Gordon S, eds. The Innate Immune Response To Infection Washington, DC: ASM Press; 2004:465.
-
- Ganz T. Defensins: antimicrobial peptides of innate immunity. Nat Rev Immunol. 2003;3:710–720. - PubMed
-
- Gallo RL, Nizet V. Endogenous production of antimicrobial peptides in innate immunity and human disease. Curr Allergy Asthma Rep. 2003;3:402–409. - PubMed
-
- Beutler B. Innate immunity: an overview. Mol Immunol. 2004;40:845–859. - PubMed
-
- Hancock RE, Lehrer R. Cationic peptides: a new source of antibiotics. Trends Biotechnol. 1998;16:82–88. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources